Larvol Delta - ROUTEC3G-A-Study-of-Complement-3-Glomerulopathy-C3G-Patients-Treated-With-Iptacopan-Through-an-Early-Access-Program-in-Spain

Fabhalta (iptacopan) - Novartis

http://clinicaltrials.gov/ct2/show/NCT07598448

Sep 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next